Pursuant to the provisions of Regulation 32 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019 regarding 'Format on statement of Deviation or Variation for proceeds of public issue, rights issue, preferential issue, Qualified Institutions Placement (QIP) etc.", we hereby confirm that there is no deviation in the use of proceeds from the objects stated in the prospectus dated September 09, 2020 issued for the Initial Public Offering of equity shares of the Company. A Nil Statement of Deviation, duly reviewed by the Audit Committee of the Company in their meeting held on May 25, 2022 is given in 'Annexure-A''''. The proceeds raised by the Company through the Initial Public Offering of equity shares of the Company, during the half year ended March 31, 2022, have been utilized for the objects as stated in prospectus dated September 09, 2020.